Market Place
Sourcing Support
All News #Library
Sciences
Charles River Highlights Effectiveness of VCGs in Toxicology
21 Apr 2026 //
PHARMIWEB
Charles River, Valo Health Find Lupus Therapy with AI Platform
25 Mar 2025 //
BUSINESSWIRE
Charles River Announces Agreement with Singapore General Hospital
25 Feb 2025 //
BUSINESSWIRE
Charles River Expands Apollo Ecosystem, Offering Client Experiences
21 Jan 2025 //
BUSINESSWIRE
Lundbeck taps Charles River for AI-enabled neuro drug discovery
02 Oct 2024 //
FIERCE BIOTECH
Charles collaborates with Gates University for lentiviral vector manufacturing.
25 Jun 2024 //
BUSINESSWIRE
Charles River And Captain T Cell Partner On Cell Therapy Manufacturing
17 Jun 2024 //
PRESS RELEASE
Charles River Launches Viral Vector Tech Transfer For Gene Therapy Safety
30 May 2024 //
PRESS RELEASE
Charles River Lab Launches Viral Vector Reference Materials to Streamline
02 May 2024 //
PRESS RELEASE
Charles River And Navega Partner On Gene Therapy Manufacturing
14 Mar 2024 //
PRESS RELEASE
Charles River LabCollaborates with Pluristyx, Expanding its Portfolio
20 Feb 2024 //
PRESS RELEASE
Charles River Rep/Cap Plasmids to Streamline Adeno-Associated Viral Vector
16 Jan 2024 //
PRESS RELEASE
Charles River Labs snaps up early-stage CRO for $510M
15 Feb 2019 //
BIOPHARMA DIVE
Charles River drops $510M to bag non-clinical CRO
13 Feb 2019 //
ENDPTS
Charles River Laboratories Signs Binding Offer to Acquire Citoxlab
13 Feb 2019 //
BIOSPACE
Charles River updates its research database with addition of new tumor models
16 Nov 2018 //
FIERCE BIOTECH
Copyright © 2026 LePro PharmaCompass OPC Private Limited, All rights reserved.